Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension.
Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension. Chest. 2000 Oct; 118(4):1077-82.
View in:
PubMed
subject areas
Adult
Antihypertensive Agents
Cardiac Catheterization
Cardiac Output
Echocardiography, Doppler
Epoprostenol
Female
Hemodynamics
Humans
Hypertension, Pulmonary
Infusions, Intravenous
Male
Middle Aged
Pulmonary Wedge Pressure
Scleroderma, Systemic
Total Lung Capacity
authors with profiles
Charlie B. Strange
Richard M. Silver
Marcy B. Bolster